AAAAAA

   
Results: 1-8 |
Results: 8
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential
Authors: Koek, W Vacher, B Cosi, C Assie, MB Patoiseau, JF Pauwels, PJ Colpaert, FC
Citation: W. Koek et al., 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential, EUR J PHARM, 420(2-3), 2001, pp. 103-112
In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats
Authors: Koek, W Assie, MB Zernig, G France, CP
Citation: W. Koek et al., In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats, PSYCHOPHAR, 149(4), 2000, pp. 377-387
Estimation of apparent pA(2) values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats
Authors: Assie, MB Koek, W
Citation: Mb. Assie et W. Koek, Estimation of apparent pA(2) values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats, EUR J PHARM, 409(2), 2000, pp. 173-177
[H-3]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT1Aand non-5-HT1A receptors
Authors: Assie, MB Koek, W
Citation: Mb. Assie et W. Koek, [H-3]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT1Aand non-5-HT1A receptors, BR J PHARM, 130(6), 2000, pp. 1348-1352
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine
Authors: John, GW Pauwels, PJ Perez, M Halazy, S Le Grand, B Verscheure, Y Valentin, JP Palmier, C Wurch, T Chopin, P Marien, M Kleven, MS Koek, W Assie, MB Carilla-Durand, E Tarayre, JP Colpaert, FC
Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95
Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors
Authors: Vacher, B Bonnaud, B Funes, P Jubault, N Koek, W Assie, MB Cosi, C Kleven, M
Citation: B. Vacher et al., Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors, J MED CHEM, 42(9), 1999, pp. 1648-1660
Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity
Authors: Assie, MB Cosi, C Koek, W
Citation: Mb. Assie et al., Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity, EUR J PHARM, 386(1), 1999, pp. 97-103
Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors
Authors: Vacher, B Bonnaud, B Funes, P Jubault, N Koek, W Assie, MB Cosi, C
Citation: B. Vacher et al., Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors, J MED CHEM, 41(25), 1998, pp. 5070-5083
Risultati: 1-8 |